DK1715859T3 - Fremgangsmåde til behandling og diagnosticering af åndedrætsforstyrrelser i sövnen ved hjælp af zonisamid og midler til at gennemföre fremgangsmåden - Google Patents

Fremgangsmåde til behandling og diagnosticering af åndedrætsforstyrrelser i sövnen ved hjælp af zonisamid og midler til at gennemföre fremgangsmåden

Info

Publication number: DK1715859T3
Authority: DK; Denmark
Prior art keywords: zonisamide; treating; osa; sleep; carrying
Prior art date: 2004-02-17

Application number

DK05711057T

Other languages

Danish (da)

English (en)

Inventor

Jan Hedner

Ludger Grote

Kaj Stenloef

Original Assignee

Cereuscience Ab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-02-17

Filing date

2005-02-15

Publication date

2009-02-16

2005-02-15 Application filed by Cereuscience Ab filed Critical Cereuscience Ab

2009-02-16 Application granted granted Critical

2009-02-16 Publication of DK1715859T3 publication Critical patent/DK1715859T3/da

Links

UBQNRHZMVUUOMG-UHFFFAOYSA-N zonisamide Chemical compound C1=CC=C2C(CS(=O)(=O)N)=NOC2=C1 UBQNRHZMVUUOMG-UHFFFAOYSA-N 0.000 title abstract 5
229960002911 zonisamide Drugs 0.000 title abstract 5
238000000034 method Methods 0.000 title abstract 3
208000023504 respiratory system disease Diseases 0.000 title 1
208000001797 obstructive sleep apnea Diseases 0.000 abstract 4
238000004519 manufacturing process Methods 0.000 abstract 2
238000003745 diagnosis Methods 0.000 abstract 1
239000003814 drug Substances 0.000 abstract 1
239000003937 drug carrier Substances 0.000 abstract 1
210000003097 mucus Anatomy 0.000 abstract 1
230000001681 protective effect Effects 0.000 abstract 1
230000029058 respiratory gaseous exchange Effects 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
- A61K31/423—Oxazoles condensed with carbocyclic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives

Landscapes

Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Epidemiology (AREA)
General Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Anesthesiology (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Pulmonology (AREA)
Neurosurgery (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Test And Diagnosis Of Digital Computers (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Emergency Protection Circuit Devices (AREA)

DK05711057T 2004-02-17 2005-02-15 Fremgangsmåde til behandling og diagnosticering af åndedrætsforstyrrelser i sövnen ved hjælp af zonisamid og midler til at gennemföre fremgangsmåden DK1715859T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
SE0400378A SE0400378D0 (sv)	2004-02-17	2004-02-17	Sätt att behandla och diagnostisera andningsstörningar i sömnen och medel för att utföra sättet
PCT/SE2005/000196 WO2005077362A1 (en)	2004-02-17	2005-02-15	Method of treating and diagnosing sleep disordered breathing using zonisamide and means for carrying out the method

Publications (1)

Publication Number	Publication Date
DK1715859T3 true DK1715859T3 (da)	2009-02-16

Family

ID=31974257

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK05711057T DK1715859T3 (da)	2004-02-17	2005-02-15	Fremgangsmåde til behandling og diagnosticering af åndedrætsforstyrrelser i sövnen ved hjælp af zonisamid og midler til at gennemföre fremgangsmåden

Country Status (14)

Country	Link
US (1)	US7655681B2 (de)
EP (1)	EP1715859B1 (de)
JP (1)	JP2007523079A (de)
CN (1)	CN100558358C (de)
AT (1)	ATE410163T1 (de)
AU (1)	AU2005212149B2 (de)
CA (1)	CA2555149C (de)
DE (1)	DE602005010213D1 (de)
DK (1)	DK1715859T3 (de)
ES (1)	ES2317196T3 (de)
NZ (1)	NZ548943A (de)
SE (1)	SE0400378D0 (de)
SI (1)	SI1715859T1 (de)
WO (1)	WO2005077362A1 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
HUE034290T2 (en)	2003-04-29	2018-02-28	Orexigen Therapeutics Inc	Preparations containing opioid antagonist and bupropion to affect weight loss
CN101291663A (zh) *	2005-09-16	2008-10-22	赛诺科学股份公司	预防和治疗睡眠呼吸障碍的方法和工具
CA2630624C (en)	2005-11-22	2013-08-06	Orexigen Therapeutics, Inc.	Compositions and methods for increasing insulin sensitivity
PT1954241E (pt) *	2005-11-28	2012-06-01	Orexigen Therapeutics Inc	Formulação de zonisamida de libertação sustentada
US8916195B2 (en)	2006-06-05	2014-12-23	Orexigen Therapeutics, Inc.	Sustained release formulation of naltrexone
KR20170077291A (ko)	2006-11-09	2017-07-05	오렉시젠 세러퓨틱스 인크.	단위 용량 팩키지
JP2011521973A (ja)	2008-05-30	2011-07-28	オレキシジェン・セラピューティクス・インコーポレーテッド	内臓脂肪の状態を処置するための方法
CN102781446A (zh) *	2010-01-07	2012-11-14	维瓦斯公司	采用碳酸酐酶抑制剂和另外的活性剂的组合治疗阻塞性睡眠呼吸暂停综合征
ES2762113T3 (es)	2010-01-11	2020-05-22	Nalpropion Pharmaceuticals Inc	Métodos de proporcionar terapia de pérdida de peso en pacientes con depresión mayor
EP3639733B1 (de) *	2012-05-30	2022-10-26	ResMed Sensor Technologies Limited	Vorrichtung zur überwachung der kardiopulmonaren gesundheit
LT3730132T (lt)	2012-06-06	2022-08-25	Nalpropion Pharmaceuticals Llc	Kompozicija, skirta panaudoti pacientų su didele širdies ir kraujagyslių ligų rizika antsvorio ir nutukimo gydymo būde
US10525219B2 (en)	2012-06-26	2020-01-07	Resmed Sensor Technologies Limited	Methods and apparatus for monitoring and treating respiratory insufficiency
US10617694B2 (en) *	2016-05-11	2020-04-14	Jan Hedner	Sultiame for the treatment of sleep apnea
CN112259179A (zh) *	2020-10-09	2021-01-22	首都医科大学宣武医院	一种患者日志生成方法及装置
US20240306982A1 (en) *	2023-03-16	2024-09-19	Laura Schneider	Method for treating sleep apnea/hypopnea

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6489350B1 (en) *	1999-09-15	2002-12-03	Elan Pharmaceuticals, Inc.	Methods for treating neuropathic pain using heteroarylmethanesulfonamides
SE0000601D0 (sv) *	2000-02-24	2000-02-24	Jan Hedner	Sätt att behandla och diagnostisera andningsstörningar i sömnen och medel för att utföra sättet
EP3173082A1 (de) *	2002-05-17	2017-05-31	Duke University	Verfahren zur behandlung von adipositas

2004
- 2004-02-17 SE SE0400378A patent/SE0400378D0/xx unknown
2005
- 2005-02-15 CN CNB2005800049089A patent/CN100558358C/zh not_active Expired - Fee Related
- 2005-02-15 US US10/598,114 patent/US7655681B2/en not_active Expired - Lifetime
- 2005-02-15 EP EP05711057A patent/EP1715859B1/de not_active Expired - Lifetime
- 2005-02-15 AT AT05711057T patent/ATE410163T1/de not_active IP Right Cessation
- 2005-02-15 AU AU2005212149A patent/AU2005212149B2/en not_active Ceased
- 2005-02-15 DK DK05711057T patent/DK1715859T3/da active
- 2005-02-15 DE DE602005010213T patent/DE602005010213D1/de not_active Expired - Lifetime
- 2005-02-15 JP JP2006553094A patent/JP2007523079A/ja active Pending
- 2005-02-15 SI SI200530544T patent/SI1715859T1/sl unknown
- 2005-02-15 NZ NZ548943A patent/NZ548943A/en not_active IP Right Cessation
- 2005-02-15 ES ES05711057T patent/ES2317196T3/es not_active Expired - Lifetime
- 2005-02-15 CA CA2555149A patent/CA2555149C/en not_active Expired - Fee Related
- 2005-02-15 WO PCT/SE2005/000196 patent/WO2005077362A1/en not_active Ceased

Also Published As

Publication number	Publication date
SI1715859T1 (sl)	2009-06-30
JP2007523079A (ja)	2007-08-16
CA2555149C (en)	2014-01-21
ATE410163T1 (de)	2008-10-15
ES2317196T3 (es)	2009-04-16
NZ548943A (en)	2010-06-25
EP1715859A1 (de)	2006-11-02
US20070281005A1 (en)	2007-12-06
WO2005077362A1 (en)	2005-08-25
EP1715859B1 (de)	2008-10-08
AU2005212149B2 (en)	2010-02-11
CN100558358C (zh)	2009-11-11
US7655681B2 (en)	2010-02-02
CA2555149A1 (en)	2005-08-25
CN1917874A (zh)	2007-02-21
SE0400378D0 (sv)	2004-02-17
DE602005010213D1 (de)	2008-11-20
AU2005212149A1 (en)	2005-08-25

Similar Documents

Publication	Publication Date	Title
DK1715859T3 (da)	2009-02-16	Fremgangsmåde til behandling og diagnosticering af åndedrætsforstyrrelser i sövnen ved hjælp af zonisamid og midler til at gennemföre fremgangsmåden
SG169233A1 (en)	2011-03-30	Pharmaceutical compositions comprising apomorphine for pulmonary inhalation
EA200800663A1 (ru)	2008-10-30	Способ и средство профилактики и лечения нарушенного дыхания во время сна
WO2008022189A3 (en)	2008-11-13	Administration of high potency platinum compound formulations by inhalation
DK1742624T3 (da)	2010-03-08	Dopamin-agonist-kombinationsterapi med sedativer til forbedring af søvnkvalitet
JP2009539961A5 (de)	2010-07-29
MX2012007813A (es)	2012-08-01	Tratamiento del sindrome de apnea obstructiva del sueño con una combinacion de un hinibidor de anhidrasa carbonica y un agente activo adicional.
UA107578C2 (uk)	2015-01-26	Комбінована терапія при лікуванні діабету
JP2009537553A5 (de)	2012-01-05
EA200700214A1 (ru)	2007-06-29	Мемантин в качестве дополнительной терапии к атипичным антипсихотическим средствам у больных шизофренией
PT2111868E (pt)	2013-10-17	Utilização de albumina humana terapêutica na preparação de um medicamento para o tratamento de doentes sofrendo de distúrbios cognitivos
Giannasi et al.	2013	Efficacy of an oral appliance for the treatment of obstructive sleep apnea.
MX2009011900A (es)	2010-01-20	Curacion de herida diabetica.
DE502005010170D1 (de)	2010-10-14	Neue langwirksame beta-2-agonisten, und deren verwendung als arzneimittel
SE0000601D0 (sv)	2000-02-24	Sätt att behandla och diagnostisera andningsstörningar i sömnen och medel för att utföra sättet
NO20054767L (no)	2005-12-21	Sammensetninger omfattende apomorfin for inhalering i lunge
NO20064964L (no)	2006-10-30	Behandling av svekket respiratorisk funksjon
NO20091659L (no)	2009-05-26	Fremgangsmater for behandling av disruptive oppforselsforstyrrelser
EA200701077A1 (ru)	2008-04-28	Применение конъюгатов липидов при лечении заболеваний
WO2005110052A3 (en)	2006-03-02	The use of inhaled gaseous nitric oxide as a mucolytic agent or expectorant
JP2010523662A5 (de)	2011-05-19
RU2009141168A (ru)	2011-05-20	Способы и композиции, содержащие дезвенлафаксин или дулоксетин, для лечения расстройств дыхания во время сна
MXPA04002401A (es)	2004-05-31	Nuevos medicamentos para inhalacion.
BR0311180A (pt)	2005-03-01	Métodos para o tratamento de doenças e condições respiratórias utilizando um inibidor seletivo da inos
IS8373A (is)	2006-03-24	Notkun oxkarbasepíns til að meðhöndla sársauka vegna sykursýkisfjöltauga-kvilla og til að bæta svefn